Surmodics, Inc. (SRDX)

Market Cap	268.81M
Revenue (ttm)	102.97M
Net Income (ttm)	-35.96M
Shares Out	14.13M
EPS (ttm)	-2.58
PE Ratio	n/a
Forward PE	81.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,921
Open	18.53
Previous Close	18.23
Day's Range	18.36 - 19.03
52-Week Range	16.00 - 39.99
Beta	1.02
Analysts	Buy
Price Target	60.00 (+215.46%)
Earnings Date	Jul 26, 2023

About SRDX

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to pr...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Mar 4, 1998
• Employees: 447
• Stock Exchange: NASDAQ
• Ticker Symbol: SRDX

Analyst Forecast

According to 2 analysts, the average rating for SRDX stock is "Buy." The 12-month stock price forecast is $60.0, which is an increase of 215.46% from the latest price.

Price Target

$60.0

(215.46% upside)

Analyst Consensus: Buy